TY  - GEN
AU  - Berg,Stacey L
AU  - Blaney,Susan M
AU  - Devidas,Meenakshi
AU  - Lampkin,Tom A
AU  - Murgo,Anthony
AU  - Bernstein,Mark
AU  - Billett,Amy
AU  - Kurtzberg,Joanne
AU  - Reaman,Greg
AU  - Gaynon,Paul
AU  - Whitlock,James
AU  - Krailo,Mark
AU  - Harris,Michael B
TI  - Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group
SN  - 0732-183X
PY  - 2005///0624
KW  - Adolescent
KW  - Adult
KW  - Arabinonucleosides
KW  - administration & dosage
KW  - Child
KW  - Child, Preschool
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Infant
KW  - Infusions, Intravenous
KW  - Leukemia, T-Cell
KW  - drug therapy
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Neoplasm Staging
KW  - Recurrence
KW  - Risk Assessment
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1200/JCO.2005.03.426
ER  -